Skip to main content
OpenTrials

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,003 public trials 2,033 recruiting studies
Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Completed

Thiopurine EnhAnced Maintenance Therapy

NCT02912676

Conditions
Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +10 more
Locations
  • Aarhus University Hospital Skejby Skejby, Aarhus, Denmark
  • Odense University Hospital, Dept. Pediatric Oncology Odense, Odense C, Denmark
  • Department of Pediatrics, Rigshospitalet Copenhagen, Denmark
  • Rigshospitalet, Department of Hematology Copenhagen, Denmark
View Trial Details
Completed

Radiation Therapy and Chemotherapy in Treating Patients With Hodgkin's Disease

NCT00002561

Conditions
Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin Lymphoma, +7 more
Locations
  • Tom Baker Cancer Centre Calgary, Alberta, Canada
  • Cross Cancer Institute Edmonton, Alberta, Canada
  • BCCA - Vancouver Island Cancer Centre Victoria, British Columbia, Canada
  • The Vitalite Health Network - Dr. Leon Richard Moncton, New Brunswick, Canada
View all 22 locations
View Trial Details
Completed

Dasatinib and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia

NCT00720109

Conditions
Acute Lymphoblastic Leukemia, Adult B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1, Childhood B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1, +11 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Phoenix Childrens Hospital Phoenix, Arizona, United States
  • Banner University Medical Center - Tucson Tucson, Arizona, United States
View all 134 locations
View Trial Details
Completed

Flavopiridol in Treating Patients With Previously Untreated or Relapsed Mantle Cell Lymphoma

NCT00005074

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations
  • Nova Scotia Cancer Centre Halifax, Nova Scotia, Canada
  • Cancer Care Ontario-Hamilton Regional Cancer Centre Hamilton, Ontario, Canada
  • Toronto General Hospital Toronto, Ontario, Canada
  • Humber River Regional Hospital Weston, Ontario, Canada
View Trial Details
Completed

Combination Chemotherapy in Hodgkin's Disease or Non-Hodgkin's Lymphoma Not Responding to Previous Treatment

NCT00014209

Conditions
Hemic and Lymphatic Diseases, Hodgkin Disease, Immune System Diseases, +12 more
Locations
  • Tom Baker Cancer Center - Calgary Calgary, Alberta, Canada
  • Cross Cancer Institute Edmonton, Alberta, Canada
  • Moncton Hospital Moncton, New Brunswick, Canada
  • Newfoundland Cancer Treatment and Research Foundation St. John's, Newfoundland and Labrador, Canada
View all 13 locations
View Trial Details

Related conditions